Our findings provide new insights into the molecular mechanisms underlying PM2.5-induced lung damage, and they lay the groundwork for future research into GARP-targeting therapies and natural compounds for the treatment of respiratory diseases. The gene discussed is LRRC32; the disease is respiratory system disorder.